Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: A survival-based analysis

Transplantation

Volumn 91, Issue 5, 2011, Pages 575-582

  Máthé, Zoltan ^a   Tagkalos, Evangelos ^b   Paul, Andreas ^a   Molmenti, Ernesto P ^c   Kóbori, László ^a   Fouzas, Ioannis ^d   Beckebaum, Susanne ^a   Sotiropoulos, Georgios C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Extended indications; Liver metastases; Liver transplantation; NET; Neuroendocrine tumors; Pancreatic malignancy; Scoring systems

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; GASTRINOMA; GLUCAGONOMA; GRAFT RECIPIENT; HUMAN; LIVER METASTASIS; LIVER TRANSPLANTATION; OVERALL SURVIVAL; PANCREAS ISLET CELL TUMOR; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL TIME; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; CARCINOMA, NEUROENDOCRINE; CHILD; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79952191240     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182081312     Document Type: Article

References (39)

1. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987; 5: 1502.
2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934.
3. Soga J, Yakuwa Y. Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999; 5: 211.
4. Thompson GB, van Heerden JA, Grant CS, et al. Islet cell carcinomas of the pancreas: A twenty-year experience. Surgery 1988; 104: 1011.
5. Søreide O, Berstad T, Bakka A, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 1992; 111: 48.
6. Que FG, Nagorney DM, Batts KP, et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169: 36.
7. Frilling A, Sotiropoulos GC, Li J, et al. Multimodal management of neuroendocrine liver metastases. HPB (Oxford) 2010; 12: 361.
8. O'Grady JG, Polson RJ, Rolles K, et al. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207: 373.
9. Iwatsuki S, Starzl TE, Todo S, et al. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: A survival report. Transplant Proc 1988; 20: S498.
10. Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 1997; 225: 355.
11. Le Treut YP, Grégoire E, Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: An 85-case French multicentric report. Am J Transplant 2008; 8: 1205.
12. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients. Transplantation 1998; 66: 1307.
13. Makowka L, Tzakis AG, Mazzaferro V, et al. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989; 168: 107.
14. Alsina AE, Bartus S, Hull D, et al. Liver transplant for metastatic neuroendocrine tumor. J Clin Gastroenterol 1990; 12: 533.
15. Bramley PN, Lodge JP, Losowsky MS, et al. Treatment of metastatic VIPoma by liver transplantation. Clin Transplant 1990; 4: 276.
16. Mieles L, Todo S, Tzakis A, et al. Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant 1990; 4: 63.
17. Lobe TE, Vera SR, Bowman LC, et al. Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg 1992; 27: 227.
18. Wenisch HJ, Markus BH, Herrmann GH, et al. [Multi-visceral upper abdominal resection and orthotopic liver transplantation-A surgical treatment concept for regionally metastatic tumors of the endocrine pancreas.] Zentralbl Chir 1992; 117: 334.
19. Farmer DG, Shaked A, Colonna JO 2nd, et al. Radical resection combined with liver transplantation for foregut tumors. Am Surg 1993;59: 806.
20. Knechtle SJ, Kalayoglu M, D'Alessandro AM, et al. Should abdominal cluster transplantation be abandoned? Transplant Proc 1993; 25: 1361.
21. Anthuber M, Jauch KW, Briegel J, et al. Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg 1996; 20: 73.
22. Dousset B, Saint-Marc O, Pitre J, et al. Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation. World J Surg 1996; 20: 908.
23. Lang H, Schlitt HJ, Schmidt H, et al. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas-A single center experience with ten patients. Langenbecks Arch Surg 1999; 384: 370.
24. Ringe B, Lorf T, Döpkens K, et al. Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors: Role of liver transplantation. World J Surg 2001; 25: 697.
25. Fernández JA, Robles R, Marín C, et al. Role of liver transplantation in the management of metastatic neuroendocrine tumors. Transplant Proc 2003; 35: 1832.
26. Florman S, Toure B, Kim L, et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 2004; 8: 208.
27. Frilling A, Malago M, Weber F, et al. Liver transplantation for patients with metastatic endocrine tumors: Single-center experience with 15 patients. Liver Transpl 2006; 12: 1089.
28. Van Vilsteren FG, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transpl 2006; 12: 448.
29. Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 2007; 13: 327.
30. Bonaccorsi-Riani E, Apestegui C, Jouret-Mourin A, et al. Liver transplantation and neuroendocrine tumors: Lessons from a single centre experience and from the literature review. Transpl Int 2010; 23: 668.
31. Arnold JC, O'Grady JG, Bird GL, et al. Liver transplantation for primary and secondary hepatic apudomas. Br J Surg 1989; 76: 248.
32. Olthoff KM, Millis JM, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990; 125: 1261.
33. Curtiss SI, Mor E, Schwartz ME, et al. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg 1995; 180: 184.
34. Pascher A, Steinmüller T, Radke C, et al. Primary and secondary hepatic manifestation of neuroendocrine tumors. Langenbecks Arch Surg 2000; 385: 265.
35. Olausson M, Friman S, Cahlin C, et al. Indications and results of liver transplantation in patients with neuroendocrine tumors. World J Surg 2002; 26: 998.
36. Marín C, Robles R, Fernández JA, et al. Role of liver transplantation in the management of unresectable neuroendocrine liver metastases. Transplant Proc 2007; 39: 2302.
37. Rosenau J, Bahr MJ, von Wasielewski R, et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002; 73: 386.
38. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation? J Hepatol 2007; 47: 460.
39. Steinmüller T, Kianmanesh R, Falconi M, et al. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: Foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008; 87: 47.